Do changing toll-like receptor profiles in different layers and grades of osteoarthritis cartilage reflect disease severity?

Journal of Rheumatology

Volumn 40, Issue 5, 2013, Pages 695-702

  Barreto, Gonçalo ^a   Sillat, Tarvo ^a   Soininen, Antti ^b   Ylinen, Pekka ^b   Salem, Abdelhakim ^a   Konttinen, Yrjö T ^a,b,c   Al Samadi, Ahmed ^a   Nordström, Dan C E ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORTON Invalid Foundation   (Finland)

^c COXA Hospital for Joint Replacement ^*  (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cartilage; Chondrocytes; Immunohistochemistry; Osteoarthritis

Indexed keywords

CATHEPSIN; PROTEOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; MORPHOMETRICS; NEGATIVE FEEDBACK; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

CARTILAGE; CHONDROCYTES; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS;

BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KNEE JOINT; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTORS;

EID: 84876924162     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121159     Document Type: Article

References (32)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.
2. Katta J, Jin Z, Ingham E, Fisher J. Biotribology of articular cartilage - a review of the recent advances. Med Eng Phys 2008;30:1349-63.
3. O'Hara BP, Urban JP, Maroudas A. Influence of cyclic loading on the nutrition of articular cartilage. Ann Rheum Dis 1990;49:536-9. (Pubitemid 20225408)
4. Bhosale AM, Richardson JB. Articular cartilage: structure, injuries and review of management. Br Med Bull 2008;87:77-95.
5. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 2012;51:249-57.
6. Konttinen YT, Sillat T, Barreto G, Ainola M, Nordström DC. Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses. Arthritis Rheum 2012;64:613-6.
7. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 2012;51:249-57.
8. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005;174:5016-23. (Pubitemid 40514462)
9. Su SL, Tsai CD, Lee CH, Salter DM, Lee HS. Expression and regulation of Toll-like receptor 2 by IL-1 β and fibronectin fragments in human articular chondrocytes. Osteoarthritis Cartilage 2005;13:879-86. (Pubitemid 41430793)
10. Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006;54:2152-63. (Pubitemid 44051072)
11. Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, et al. Toll-like receptors and chondrocytes: The lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum 2007;56:1880-93. (Pubitemid 47110387)
12. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006;14:13-29. (Pubitemid 43034086)
13. Morisato D, Anderson KV. The spätzle gene encodes a component of the extracellular signaling pathway establishing the dorsal-ventral pattern of the Drosophila embryo. Cell 1994;76:677-88.
14. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010. E-pub 2010 Jul 13.
15. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1-5. (Pubitemid 46028489)
16. Tchetina EV, Squires G, Poole AR. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005;32:876-86. (Pubitemid 40676499)
17. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585-94. (Pubitemid 32234617)
18. van Tienen TG, Heijkants RG, de Groot JH, Pennings AJ, Poole AR, Veth RP, et al. Presence and mechanism of knee articular cartilage degeneration after meniscal reconstruction in dogs. Osteoarthritis Cartilage 2003;11:78-84. (Pubitemid 36157576)
19. Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, et al. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 2008;16:615-23. (Pubitemid 351545558)
20. Jürgensen HJ, Madsen DH, Ingvarsen S, Melander MC, Gårdsvoll H, Patthy L, et al. A novel functional role of collagen glycosylation: interaction with the endocytic collagen receptor uparap/ENDO180. J Biol Chem 2011;286:32736-48.
21. Howard MJ, Chambers MG, Mason RM, Isacke CM. Distribution of Endo180 receptor and ligand in developing articular cartilage. Osteoarthritis Cartilage 2004;12:74-82. (Pubitemid 38111553)
22. Squires GR, Okouneff S, Ionescu M, Poole AR. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 2003;48:1261-70. (Pubitemid 36554525)
23. Pratta MA, Yao W, Decicco C, Tortorella MD, Liu RQ, Copeland RA, et al. Aggrecan protects cartilage collagen from proteolytic cleavage. J Biol Chem 2003;278:45539-45. (Pubitemid 37432694)
24. Ellman MB, Kim JS, An HS, Chen D, Ranjan KC, An J, et al. Toll-like receptor adaptor signaling molecule MyD88 on intervertebral disk homeostasis: In vitro, ex vivo studies. Gene 2012;505:283-90.
25. Papathanasiou I, Malizos KN, Poultsides L, Karachalios T, Oikonomou P, Tsezou A. The catabolic role of toll-like receptor 2 (TLR-2) mediated by the NF-κB pathway in septic arthritis. J Orthop Res 2011;29:247-51.
26. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003;171:6680-9. (Pubitemid 37532100)
27. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009;182:7244-53.
28. Chockalingam A, Cameron JL, Brooks JC, Leifer CA. Negative regulation of signaling by a soluble form of toll-like receptor 9. Eur J Immunol 2011;41:2176-84.
29. Tamaki Y, Takakubo Y, Goto K, Hirayama T, Sasaki K, Konttinen YT, et al. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants. J Rheumatol 2009;36:598-608.
30. Sohn DH, Sokolove J, Sharpe O, Erhart JC, Chandra PE, Lahey LJ, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012;14:R7.
31. Myles A, Aggarwal A. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology 2011;50:481-8.
32. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-58. (Pubitemid 40835033)